Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
19 hedge funds and large institutions have $1.57M invested in Celgene Corporation Contingent Value Rights in 2017 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
21% more capital invested
Capital invested by funds: $1.29M → $1.57M (+$275K)
10% less funds holding
Funds holding: 21 → 19 (-2)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$167 |
| 2 |
Wells Fargo
San Francisco,
California
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$8.97K |
| 2 |
First Manhattan
New York
|
-$2.44K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.71K |
| 4 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
-$1K |
| 5 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$683 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Cannell & Co
New York
| $506K | – | – | – |
|
|
BC
2
Birchview Capital
Burlington,
Vermont
| $443K | – | – | – |
|
|
FA
3
FCG Advisors
Chatham,
New Jersey
| $307K | -$683 | -559 | -0.3% |
|
|
DC
4
Davenport & Co
Richmond,
Virginia
| $178K | – | – | – |
|
|
MSTVIM
5
Messner & Smith Theme Value Investment Management
San Diego,
California
| $31K | – | – | – |
|
6
California Public Employees Retirement System
Sacramento,
California
| $27K | – | – | – |
|
|
CL
7
CSS LLC
Chicago,
Illinois
| $26K | – | – | – |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $15K | -$1.71K | -1,400 | -12% |
|
|
9
Bank of America
Charlotte,
North Carolina
| $15K | +$167 | +137 | +1% |
|
|
10
First Manhattan
New York
| $12K | -$2.44K | -2,000 | -20% |
|
11
Morgan Stanley
New York
| $4K | – | – | – |
|
|
12
UBS Group
Zurich,
Switzerland
| $2K | -$8.97K | -7,338 | -87% |
|
|
BWM
13
Baystate Wealth Management
Boston,
Massachusetts
| $1K | – | – | – |
|
|
FANJ
14
Financial Architects (New Jersey)
Marlton,
New Jersey
| – | -$1K | -450 | Closed |
|
|
15
Wells Fargo
San Francisco,
California
| – | +$1 | +1 | +33% |
|
CELGZ Hedge Fund Activity: Q3 2017 in Review
19 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q3 2017, worth a combined $1.57M — up 21% from $1.29M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CELGZ and 0 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Bank of America, adding an estimated $167. The largest seller was UBS Group, cutting an estimated $8.97K.
- 19 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q3 2017, down from 21 in Q2 2017.
- Funds reported $1.57M of Celgene Corporation Contingent Value Rights stock for Q3 2017, up 21% quarter-over-quarter.
- 0 funds opened new Celgene Corporation Contingent Value Rights positions in Q3 2017 and 2 closed out, a net change of -2 holders.
- The largest Celgene Corporation Contingent Value Rights buyer in Q3 2017 was Bank of America, an estimated $167 added.
- The largest Celgene Corporation Contingent Value Rights seller in Q3 2017 was UBS Group, an estimated $8.97K sold.
Based on aggregated 13F filings for Q3 2017.